Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection

被引:0
作者
Davide Eletto
Siobhan O. Burns
Ivan Angulo
Vincent Plagnol
Kimberly C. Gilmour
Frances Henriquez
James Curtis
Miguel Gaspar
Karolin Nowak
Vanessa Daza-Cajigal
Dinakantha Kumararatne
Rainer Doffinger
Adrian J. Thrasher
Sergey Nejentsev
机构
[1] University of Cambridge,Department of Medicine
[2] University College London Institute of Immunity and Transplantation,Department of Immunology
[3] Royal Free London NHS Foundation Trust,Department of Clinical Biochemistry and Immunology
[4] University College London Genetics Institute,undefined
[5] University College London,undefined
[6] Great Ormond Street Hospital for Children NHS Foundation Trust,undefined
[7] University College London Institute of Child Health,undefined
[8] Addenbrooke’s Hospital,undefined
来源
Nature Communications | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in genes encoding components of the immune system cause primary immunodeficiencies. Here, we study a patient with recurrent atypical mycobacterial infection and early-onset metastatic bladder carcinoma. Exome sequencing identified two homozygous missense germline mutations, P733L and P832S, in the JAK1 protein that mediates signalling from multiple cytokine receptors. Cells from this patient exhibit reduced JAK1 and STAT phosphorylation following cytokine stimulations, reduced induction of expression of interferon-regulated genes and dysregulated cytokine production; which are indicative of signalling defects in multiple immune response pathways including Interferon-γ production. Reconstitution experiments in the JAK1-deficient cells demonstrate that the impaired JAK1 function is mainly attributable to the effect of the P733L mutation. Further analyses of the mutant protein reveal a phosphorylation-independent role of JAK1 in signal transduction. These findings clarify JAK1 signalling mechanisms and demonstrate a critical function of JAK1 in protection against mycobacterial infection and possibly the immunological surveillance of cancer.
引用
收藏
相关论文
共 53 条
  • [11] Russell SM(2007) mutation leading to constitutive signalling causes polycythaemia vera N. Engl. J. Med. 356 459-220
  • [12] Minegishi Y(2013) exon 12 mutations in polycythemia vera and idiopathic erythrocytosis Sci. Rep. 3 3042-262
  • [13] Kreins AY(2013)JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations Nature 493 216-1223
  • [14] James C(2002)Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants Science 296 261-905
  • [15] Scott LM(2013)A human genome diversity cell line panel Nat. Struct. Mol. Biol. 20 1221-8030
  • [16] Ren Y(2016)Structure of a pseudokinase-domain switch that controls oncogenic activation of Jak kinases Structure 24 897-956
  • [17] Fu W(2014)The structural basis for class II cytokine receptor recognition by JAK1 Proc. Natl Acad. Sci. USA 111 8025-47963
  • [18] Cann HM(2000)Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition Mol. Cell. Biol. 20 947-976
  • [19] Toms AV(2002)Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains J. Biol. Chem. 277 47954-758
  • [20] Ferrao R(2011)The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction Nat. Struct. Mol. Biol. 18 971-135